Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Ublituximab on Unperturbed and Perturbed Ambulatory Functions in People With Relapsing Multiple Sclerosis

NCT06629428 is registered in ClinicalTrials.gov with Georgia State University as lead sponsor.

NCT NCT06629428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06629428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Ublituximab on Unperturbed and Perturbed Ambulatory Functions in People With Relapsing Multiple Sclerosis
Lead sponsor
Georgia State University
Phase
Phase 1
Overall status
Recruiting
Start date
November 13, 2025
Completion date
December 31, 2026
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms) - relapsing-remitting